Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis

R. H. Wiesner, P. M. Grambsch, E. R. Dickson, J. Ludwig, R. L. MacCarty, E. B. Hunter, T. R. Fleming, L. D. Fisher, S. J. Beaver, Nicholas F La Russo

Research output: Contribution to journalArticle

487 Citations (Scopus)

Abstract

The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Long-term follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34%) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.

Original languageEnglish (US)
Pages (from-to)430-436
Number of pages7
JournalHepatology
Volume10
Issue number4
StatePublished - 1989

Fingerprint

Sclerosing Cholangitis
Survival Analysis
Natural History
Statistical Factor Analysis
Inflammatory Bowel Diseases
Survival
Statistical Models
Ulcerative Colitis
Bilirubin
Liver Transplantation
Patient Selection
Liver Diseases
Counseling
Hemoglobins
Multivariate Analysis
Biopsy
Liver
Serum
Population

ASJC Scopus subject areas

  • Hepatology

Cite this

Wiesner, R. H., Grambsch, P. M., Dickson, E. R., Ludwig, J., MacCarty, R. L., Hunter, E. B., ... La Russo, N. F. (1989). Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology, 10(4), 430-436.

Primary sclerosing cholangitis : Natural history, prognostic factors and survival analysis. / Wiesner, R. H.; Grambsch, P. M.; Dickson, E. R.; Ludwig, J.; MacCarty, R. L.; Hunter, E. B.; Fleming, T. R.; Fisher, L. D.; Beaver, S. J.; La Russo, Nicholas F.

In: Hepatology, Vol. 10, No. 4, 1989, p. 430-436.

Research output: Contribution to journalArticle

Wiesner, RH, Grambsch, PM, Dickson, ER, Ludwig, J, MacCarty, RL, Hunter, EB, Fleming, TR, Fisher, LD, Beaver, SJ & La Russo, NF 1989, 'Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis', Hepatology, vol. 10, no. 4, pp. 430-436.
Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology. 1989;10(4):430-436.
Wiesner, R. H. ; Grambsch, P. M. ; Dickson, E. R. ; Ludwig, J. ; MacCarty, R. L. ; Hunter, E. B. ; Fleming, T. R. ; Fisher, L. D. ; Beaver, S. J. ; La Russo, Nicholas F. / Primary sclerosing cholangitis : Natural history, prognostic factors and survival analysis. In: Hepatology. 1989 ; Vol. 10, No. 4. pp. 430-436.
@article{57f776b43bfc4aa5947ea63069872092,
title = "Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis",
abstract = "The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66{\%} of the primary sclerosing cholangitis patients were male and 71{\%} had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Long-term follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34{\%}) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.",
author = "Wiesner, {R. H.} and Grambsch, {P. M.} and Dickson, {E. R.} and J. Ludwig and MacCarty, {R. L.} and Hunter, {E. B.} and Fleming, {T. R.} and Fisher, {L. D.} and Beaver, {S. J.} and {La Russo}, {Nicholas F}",
year = "1989",
language = "English (US)",
volume = "10",
pages = "430--436",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Primary sclerosing cholangitis

T2 - Natural history, prognostic factors and survival analysis

AU - Wiesner, R. H.

AU - Grambsch, P. M.

AU - Dickson, E. R.

AU - Ludwig, J.

AU - MacCarty, R. L.

AU - Hunter, E. B.

AU - Fleming, T. R.

AU - Fisher, L. D.

AU - Beaver, S. J.

AU - La Russo, Nicholas F

PY - 1989

Y1 - 1989

N2 - The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Long-term follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34%) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.

AB - The natural history of primary sclerosing cholangitis was assessed in 174 patients; 37 were asymptomatic and 137 had symptoms related to underlying liver disease. At the time of diagnosis, the mean age was 39.9 years, 66% of the primary sclerosing cholangitis patients were male and 71% had associated inflammatory bowel disease, most commonly chronic ulcerative colitis. Long-term follow-up (mean: 6.0 years; range: 2.7 to 15.5 years) was available in all patients. During follow-up, 59 (34%) of the patients died: 55 in the symptomatic group and four in the asymptomatic group. Median survival from the time of diagnosis of primary sclerosing cholangitis at the Mayo Clinic was 11.9 years. Survival in the asymptomatic group was significantly decreased compared with that in a control population matched for age, race and sex. Multivariate analysis (Cox proportional hazards regression modeling) revealed that age, serum bilirubin concentration, blood hemoglobin concentration, presence or absence of inflammatory bowel disease and histologic stage on liver biopsy were independent predictors of high risk of dying. The development of a multivariate statistical survival model is a major step in identifying individual primary sclerosing cholangitis patients at low, moderate and high risk of dying. Such models will be useful for stratifying patients in therapeutic trials, in patient counseling and in patient selection and timing of liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0024414279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024414279&partnerID=8YFLogxK

M3 - Article

C2 - 2777204

AN - SCOPUS:0024414279

VL - 10

SP - 430

EP - 436

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -